Andere talen Synairgen plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:04 09-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,86 ^GBX	+1,74%		-4,25%	-1,92%

07/05	Koersdoel AstraZeneca verhoogd; Antofagasta verlaagd	AN
2023	Synairgen benoemt Phytome's Joseph Colliver tot CFO	AN

AstraZeneca target raised; Antofagasta lowered	07/05
Synairgen : IDWeek 2023 Poster Presentation	12-10-23
FTSE 100 Finishes Slightly Lower After Steady Session	11-10-23
Synairgen names Phytome's Joseph Colliver as CFO	11-10-23
Biotech Company Synairgen Names New CFO	11-10-23
Synairgen plc Announces Executive Changes	11-10-23
Synairgen plc Announces Board Changes	11-10-23
Synairgen promotes Marcin Mankowski to chief medical officer	03-10-23
Synairgen plc Announces Appointment of Dr. Marcin Mankowski as Chief Medical Officer	03-10-23
Synairgen narrows interim loss on reduced R&D spending	21-09-23
Synairgen looking beyond COVID in fight against respiratory illness	21-09-23
Synairgen : Interim Results	21-09-23
Earnings Flash (SNG.L) SYNAIRGEN Posts H1 Loss GBX-2.36	21-09-23
Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2023	21-09-23
Synairgen : ATS 2023 SPRINTER Poster Presentation	23-05-23
Synairgen : 2022 Annual Report	23-05-23
Synairgen CEO lays out plans for 2023 and beyond	28-04-23
Synairgen loss narrows; aims to develop SNG001	27-04-23
Earnings Flash (SNG.L) SYNAIRGEN Reports FY22 Loss GBX-8.76	27-04-23
Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2022	27-04-23

Geen resultaten voor deze zoekopdracht